Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the efficacy and safety of Gefapixant (MK-7264) in women with endometriosis-related pain; the study completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Gefapixant (gefapixant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Endometriosis-related Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-07-07